Nortech Systems Incorporated (NSYS) États Financiers et Données Historiques

Nortech Systems Incorporated (NSYS) — Prix $11.51 HealthcareMedical - Devices — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Nortech Systems Incorporated (NSYS): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Nortech Systems Incorporated a enregistré un chiffre d'affaires de $118.4M sur le dernier exercice, avec un CAGR sur 5 ans de 2.6%.

Marges des 12 derniers mois: marge brute 16.4%, marge opérationnelle 2.0%, marge nette 0.8%. Le free cash flow a progressé à un CAGR de 19.8% sur 5 ans.

Au prix actuel de $11.51, NSYS se négocie à un PER de 31.73 et un ROE de 2.99%. La capitalisation boursière s'établit à $32M.

Compte de Résultat (10 ans)

Année2016201720182019202020212022202320242025
Revenus$116.6M$112.3M$113.4M$116.3M$104.1M$115.2M$134.1M$139.3M$128.1M$118.4M
Coût des Ventes$102.8M$100.2M$100.1M$103.8M$95.7M$99.3M$113.6M$116.2M$111.4M$100.4M
Marge Brute$13.8M$12.1M$13.3M$12.6M$8.5M$15.9M$20.5M$23.1M$16.7M$18.0M
R&D00000$483000$1.5M$1.2M$1.2M$1.2M
Frais Généraux$13.2M$12.8M$12.1M$12.4M$10.5M$12.4M$15.1M$16.0M$15.2M$15.6M
Charges Opérationnelles$13.2M$12.8M$12.1M$12.4M$10.5M$13.6M$16.6M$17.2M$16.9M$16.8M
Résultat Opérationnel$629063-$1.3M$1.2M$224000-$2.1M$2.3M$3.9M$6.0M-$195000$1.2M
EBITDA$2.9M$979443$3.4M$2.4M$1.6M$10.4M$5.8M$8.0M$1.5M$2.3M
Charges d'Intérêt$550289$627555$757000$1.0M$620000$430000$411000$487000$744000$964000
Résultat Avant Impôts$78774-$2.1M$492000-$819000-$1.2M$8.0M$3.5M$5.5M-$939000$11000
Impôts$35000$375000$326000$409000$310000$859000$1.5M-$1.4M$356000$263000
Résultat Net$43774-$2.4M$166000-$1.2M-$1.5M$7.2M$2.0M$6.9M-$1.3M-$252000
BPA$0.02$-0.89$0.06$-0.46$-0.58$2.68$0.75$2.53$-0.47$-0.09
BPA Dilué$0.02$-0.89$0.06$-0.46$-0.58$2.54$0.70$2.38$-0.47$-0.09
Actions en Circulation (Diluées)$2.7M$2.7M$2.7M$2.7M$2.7M$2.8M$2.9M$2.9M$2.8M$2.8M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus$30.5M$30.3M$30.3M$33.5M
Marge Brute$5.0M$5.1M$4.7M$5.7M
Résultat Opérationnel$945000$901000$47000$623000
EBITDA$1.2M$1.2M$350000$623000
Résultat Net-$146000$897000-$34000$316000
BPA$-0.05$0.32$-0.01$0.11
BPA Dilué$-0.05$0.32$-0.01$0.11

Bilan (10 ans)

Année2016201720182019202020212022202320242025
Trésorerie$268204$472886$480000$351000$352000$643000$1.0M$960000$916000$1.7M
Placements à Court Terme0000000000
Créances$17.5M$17.6M$26.5M$26.2M$21.5M$28.5M$28.6M$33.8M$28.7M$32.2M
Stocks$20.7M$18.5M$17.0M$14.3M$13.9M$19.4M$22.4M$21.7M$21.6M$20.7M
Actifs Courants$39.5M$37.8M$45.9M$43.3M$41.0M$51.8M$54.9M$58.8M$55.3M$56.1M
Immobilisations Corporelles$10.3M$10.2M$10.2M$14.4M$15.4M$14.8M$14.3M$13.4M$14.4M$12.2M
Goodwill$3.3M$2.4M$2.4M$2.4M000000
Actifs Incorporels$1.9M$1.7M$1.5M$1.3M$1.2M$501000$422000$263000$174000$156000
Actifs Totaux$55.5M$52.1M$60.0M$61.4M$57.6M$67.1M$69.5M$75.1M$72.4M$71.9M
Dettes Fournisseurs$13.8M$11.7M$18.1M$14.0M$11.2M$12.7M$14.8M$15.9M$11.6M$12.8M
Dette à Court Terme$1.6M$1.0M$780000$444000$1.2M0000$7.0M
Passifs Courants$20.3M$18.0M$24.9M$22.2M$19.5M$22.3M$26.4M$26.6M$21.4M$29.8M
Dette à Long Terme$12.2M$12.9M$12.9M$13.3M$9.2M$9.0M$6.9M$5.8M$8.6M0
Passifs Totaux$33.2M$32.3M$38.9M$41.4M$38.9M$41.0M$41.5M$39.8M$38.4M$37.4M
Réserves$6.3M$3.9M$5.4M$4.2M$2.7M$9.8M$11.8M$18.7M$17.4M$17.1M
Capitaux Propres$22.3M$19.8M$21.1M$20.0M$18.7M$26.1M$28.1M$35.3M$34.0M$34.5M
Dette Totale$13.8M$14.2M$14.0M$20.9M$21.8M$20.2M$16.5M$14.2M$18.0M$15.7M
Dette Nette$13.5M$13.7M$13.5M$20.6M$21.4M$19.6M$15.5M$13.2M$17.1M$14.1M
Fonds de Roulement$19.2M$19.7M$21.0M$21.1M$21.5M$29.5M$28.5M$32.2M$33.9M$26.3M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$1.3M$1.7M$2.0M$1.4M
Actifs Totaux$74.8M$71.9M$76.6M$80.0M
Passifs Totaux$41.4M$37.4M$41.9M$44.6M
Capitaux Propres$33.4M$34.5M$34.7M$35.5M
Dette Totale$21.1M$15.7M$18.0M$17.9M

Tableau de Flux (10 ans)

Année2016201720182019202020212022202320242025
Résultat Net$43774-$2.4M$166000-$1.2M-$1.5M$7.2M$2.0M$6.9M-$1.3M-$252000
Amortissements$2.3M$2.5M$2.2M$2.2M$2.2M$1.9M$1.9M$2.0M$1.7M$1.3M
Stock-based Compensation$994$43200$126000$261000$68000$259000$334000$423000$461000$503000
Variation du BFR$1.7M$711239-$319000-$796000$1.3M-$9.4M$1.4M-$5.3M-$3.2M$1.4M
Cash Flow Opérationnel$3.5M$806245$2.4M$997000$1.4M-$4.5M$5.4M$1.8M-$2.2M$2.7M
CapEx-$2.0M-$927137-$1.4M-$758000-$519000-$1.3M-$2.4M-$1.3M-$1.3M-$661000
Acquisitions$3000$668786$14000000000$504000
Rachat d'Actions0-$30000-$276000-$1300000000-$1000000
Dividendes Payés0000000000
Free Cash Flow$1.6M-$120892$1.0M$239000$844000-$5.8M$3.0M$485000-$3.5M$2.1M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel-$92000$5.6M-$1.6M-$888000
CapEx-$150000-$661000-$228000-$95000
Free Cash Flow-$242000$4.9M-$1.8M-$983000
Dividendes Payés0000
Stock-based Compensation$134000$134000$126000$194000

Croissance et Marges (10 ans)

Année2016201720182019202020212022202320242025
Croissance Revenus (annuelle)-3.7%+0.9%+2.6%-10.5%+10.6%+16.5%+3.9%-8.0%-7.6%
Croissance Résultat Net (annuelle)-5687.3%+106.8%-839.8%-25.9%+562.7%-71.9%+242.0%-118.8%+80.5%
Croissance BPA (annuelle)-4550.0%+106.9%-845.5%-26.1%+562.1%-72.0%+237.3%-118.6%+80.7%
Variation Actions (annuelle)-0.1%-1.7%-1.3%-0.3%+6.2%+2.5%-0.2%-4.4%+0.7%
Croissance FCF (annuelle)-107.7%+960.3%-77.0%+253.1%-791.0%+150.8%-83.6%-825.8%+159.1%
Marge Brute11.9%10.8%11.7%10.8%8.1%13.8%15.3%16.6%13.1%15.2%
Marge Opérationnelle0.5%-1.1%1.1%0.2%-2.0%2.0%2.9%4.3%-0.2%1.0%
Marge EBITDA2.5%0.9%3.0%2.1%1.5%9.0%4.3%5.7%1.2%1.9%
Marge Nette0.0%-2.2%0.1%-1.1%-1.5%6.2%1.5%4.9%-1.0%-0.2%
Marge FCF1.4%-0.1%0.9%0.2%0.8%-5.1%2.2%0.3%-2.7%1.8%
Taux d'Imposition Effectif44.4%-18.1%66.3%-49.9%-25.1%10.7%42.2%-25.8%-37.9%2390.9%

Données par Action (10 ans)

Année2016201720182019202020212022202320242025
FCF par Action$0.57$-0.04$0.39$0.09$0.32$-2.07$1.02$0.17$-1.28$0.75
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$2.7M$2.7M$2.7M$2.7M$2.7M$2.7M$2.7M$2.7M$2.8M$2.8M

Quoi regarder en Santé / Pharma

Le pipeline R&D est l'actif invisible. Brevets qui expirent = revenus qui s'évaporent. Regardez innovation et cash flow.

Rentabilité

Rentabilité des capitaux propres2.99%
Rentabilité du capital investi3.08%
Rentabilité des actifs1.29%
Marge brute16.44%
Marge opérationnelle2.02%
Marge nette0.83%

Santé financière

Dette / Capitaux propres0.50
Ratio de liquidité1.78
Piotroski F-Score5
Altman Z-Score2.81

Ratios Clés (10 ans)

Année2016201720182019202020212022202320242025
PER194.50-4.3457.54-10.59-12.363.8616.333.72-21.89-81.83
P/B0.480.530.450.651.021.061.170.730.830.60
P/V0.090.090.080.110.180.240.250.180.220.17
Marge Brute11.9%10.8%11.7%10.8%8.1%13.8%15.3%16.6%13.1%15.2%
Marge Opérationnelle0.5%-1.1%1.1%0.2%-2.0%2.0%2.9%4.3%-0.2%1.0%
Marge Nette0.0%-2.2%0.1%-1.1%-1.5%6.2%1.5%4.9%-1.0%-0.2%

Entreprises liées: ANY · BOSC · CSAI · DAIO · FCUV · FOXX · HOLO

Explorer le secteur: Healthcare · Medical - Devices

Plus de sections de NSYS: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions